Pimavanserin for Psychosis in Parkinson’s Disease-Related Disorders: A Retrospective Chart Review

BACKGROUND: Psychosis is common in Parkinson’s disease-related disorders and is associated with significant morbidity. Pimavanserin is a newly approved treatment for Parkinson’s disease psychosis, but real-world experience with pimavanserin has been limited by small sample sizes and limited assessme...

Descripción completa

Detalles Bibliográficos
Autores principales: Sellers, Jessie, Darby, R. Ryan, Farooque, Alma, Claassen, Daniel O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584229/
https://www.ncbi.nlm.nih.gov/pubmed/30924099
http://dx.doi.org/10.1007/s40266-019-00655-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584229/
https://www.ncbi.nlm.nih.gov/pubmed/30924099
http://dx.doi.org/10.1007/s40266-019-00655-y

Ejemplares similares